Skip to main content
. 2019 Jul 9;15(2):193–199. doi: 10.5152/iao.2019.5859

Table 6.

Cholesterol granuloma symptom improvement by surgical approaches

EN OP


Symptom TS (n=39) TC (n=18) IP TC+IP (n=8) IC (n=62) IL (n=78) MF (n=33) TL (n=16) SO (n=6) Other (n=15)
Hearing loss 6/7 (86%) 2/2 (100%) 3/3 (100%) 1/1 (100%) 5/30 (17%) 17/41 (41%) N/A 0/5 (0%) 0/4 (0%) 3/8 (38%)

Headache 15/16 (94%) 6/7 (86%) 4/4 (100%) 6/6 (100%) 1/1 (100%) 6/7(86%) 4/4 (100%) N/A N/A 3/3 (100%)

Vertigo/disequilibrium 4/4 (100%) 3/4 (75%) N/A 1/1 (100%) 2/2 (100%) 5/5 (100%) N/A N/A N/A 0/2 (0%)

Diplopia 6/7 (86%) 1/1 (100%) 2/2 (100%) N/A 2/4 (50%) 5/5 (100%) 10/10 (100%) N/A N/A 2/3 (67%)

Paresis / paralysis N/A N/A N/A N/A 2/4 (50%) N/A N/A N/A N/A 0/1 (0%)

Paresthesia / pain N/A N/A 2/3 (67%) N/A 1/1 (100%) N/A 4/4 (100%) N/A N/A 2/2 (100%)

EN: Endoscopic endonasal; OP: open; TS: Transsphenoid; TC: Transphenoid transclival; IP: Infrapetrous; IC: Infracochlear; IL: Infralabyrinthine; MF: Middle Fossa; TL: Translabyrinthine; SO: Suboccipital; N/A: not applicable.